Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

The laser therapy device effectively increased hair growth in people with androgenetic alopecia.

Dermatology residents need better training to treat hair conditions in patients with skin of color.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Treating underlying metabolic and hormonal issues is key to managing female hair loss.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

Exercise is crucial for managing polycystic ovary syndrome (PCOS) and improving overall health.

Classifying curl patterns might help doctors assess and treat hair loss better.

Hirsutism greatly lowers the quality of life for Turkish women.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

A new teledermatology system improved access and reduced wait times for skin care.

Adipose stem cell-derived exosomes are safe and effective for hair regrowth in AGA patients.

Taking biotin supplements can be risky and often lacks evidence of effectiveness for skin, hair, and nail issues.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

Using quantitative traits in genetics can improve understanding and management of skin health and conditions.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Refugee patients face long wait times for dermatology care, worsening health disparities.

Teledermatology is highly effective for diagnosing and managing hair loss.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Topical metformin shows promise for dental and skin treatments, including periodontitis, hair regrowth, wound healing, and acne.

The 2024 guideline updates recommendations for genetic testing, imaging, and sperm retrieval in male infertility.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.